Over the past year, there has been an explosion in the popularity of GLP-1 receptor agonist drugs — namely Ozempic and Wegovy, which are respectively used to treat diabetes and obesity.
However, recent reports, heralded by a CNN story published on July 25, have highlighted several cases of persistent vomiting and "stomach paralysis" in people who take the drugs. The U.S. Food and Drug Administration (FDA) also told CNN that they'd received reports of people experiencing such symptoms after taking semaglutide — the active ingredient in Ozempic and Wegovy — but have not yet determined whether the problems arose from the drug itself or from underlying medical issues.
